Innoviva (INVA) Current Assets (2010 - 2026)
Innoviva (INVA) reported Current Assets of $772.6 million for Q1 2026, up 32.75% on a YoY basis from $582.0 million in Q1 2025, and up 6.2% quarter-over-quarter from $727.5 million in Q4 2025.
Innoviva (INVA) Current Assets (2010 - 2026) Analysis & Trends
Innoviva has reported Current Assets for 17 years, with the latest figure at $772.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 32.75% year-over-year to $772.6 million; the trailing twelve-month figure through Mar 2026 stood at $772.6 million (up 32.75% YoY), and the FY2025 full-year result was $727.5 million, up 31.25% from the prior year.
- Current Assets for Q1 2026 stood at $772.6 million, up from $727.5 million in the prior quarter.
- The five-year high for Current Assets was $772.6 million in Q1 2026, with the low at $16.9 million in Q3 2025.
- Historically, Current Assets has averaged $364.3 million across 5 years, with a median of $344.2 million in 2023.
- Annual changes were most pronounced in 2022 — Current Assets soared 170.02% — and 2024, when it plunged 38.8%.
- Innoviva's Current Assets stood at $443.5 million in 2022, then retreated by 22.39% to $344.2 million in 2023, then soared by 61.03% to $554.3 million in 2024, then surged by 31.25% to $727.5 million in 2025, then rose by 6.2% to $772.6 million in 2026.
- The last three Current Assets figures came in at $772.6 million (Q1 2026), $727.5 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 600.85 Mn |
| 10 | Innoviva | 1.69 Bn | 1.08 Bn | 75.83 Mn | 772.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 772.62 Mn |
| Dec 31, 2025 | 727.52 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 651.78 Mn |
| Mar 31, 2025 | 582.02 Mn |
| Dec 31, 2024 | 554.31 Mn |
| Sep 30, 2024 | 22.39 Mn |
| Jun 30, 2024 | 358.28 Mn |
| Mar 31, 2024 | 311.34 Mn |
| Dec 31, 2023 | 344.22 Mn |
| Sep 30, 2023 | 36.59 Mn |
| Jun 30, 2023 | 323.54 Mn |
| Mar 31, 2023 | 296.45 Mn |
| Dec 31, 2022 | 443.51 Mn |
| Sep 30, 2022 | 33.25 Mn |
| Jun 30, 2022 | 400.33 Mn |
| Mar 31, 2022 | 317.82 Mn |
| Dec 31, 2021 | 313.67 Mn |
| Sep 30, 2021 | 49.75 Mn |
| Jun 30, 2021 | 148.26 Mn |